<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: <z:hpo ids='HP_0011010'>Chronic</z:hpo> pain is a common problem for patients with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Most of the <z:hpo ids='HP_0011010'>chronic</z:hpo> pain in <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> has been reported to be of musculoskeletal origin, but now there seems to be different <z:hpo ids='HP_0011010'>chronic</z:hpo> pain in patients with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>CASE PRESENTATION: A 29-year-old man (Han Chinese, Hoklo) with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> experienced severe <z:hpo ids='HP_0011010'>chronic</z:hpo> pain in both feet, cutaneous thermal change, thermal hypersensitivity, focal <z:hpo ids='HP_0000969'>edema</z:hpo>, and <z:hpo ids='HP_0000975'>sweating</z:hpo> and had a history of bone fracture </plain></SENT>
<SENT sid="3" pm="."><plain>These symptoms were compatible with a diagnosis of <z:e sem="disease" ids="C0458219" disease_type="Disease or Syndrome" abbrv="">complex regional pain syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>After common <z:chebi fb="29" ids="35480">analgesics</z:chebi> failed to relieve his pain, gabapentin was added and titrated to 2000 mg/day (500 mg every six hours) in less than two weeks </plain></SENT>
<SENT sid="5" pm="."><plain>This relieved 40% of his pain and led to significant clinical improvement </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: The pathophysiology of <z:e sem="disease" ids="C0458219" disease_type="Disease or Syndrome" abbrv="">complex regional pain syndrome</z:e> includes peripheral and central sensitizations, the latter of which might be associated with the <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> in <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>In this report, we suggest that gabapentin could inhibit central sensitization as an adjunct for <z:e sem="disease" ids="C0458219" disease_type="Disease or Syndrome" abbrv="">complex regional pain syndrome</z:e> in patients with <z:e sem="disease" ids="C0024408" disease_type="Disease or Syndrome" abbrv="MJD|SCA3">Machado-Joseph disease</z:e> </plain></SENT>
</text></document>